Inventor
David A. Scheinberg
Inventor
New York, NY, US
Overview
Patents· 40 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
C07KPeptides26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C12NMicroorganisms or enzymes6%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
B82YSpecific uses or applications of nanostructures4%
C01BNon-metallic elements2%
Y02ATechnologies for adaptation to climate change2%
C07DHeterocyclic compounds2%
C12YEnzymes2%
PatentTitleYear
11,033,613Methods and compositions for treating cancer202110,900,037Targeted self-assembly of functionalized carbon nanotubes on tumors202110,858,444T cell receptor-like antibodies specific for a WTI peptide presented by HLA-A2202010,815,273Immunogenic WT-1 peptides and methods of use thereof202010,406,236Single wall nanotube constructs and uses thereof201910,239,952Anti-WT1/HLA bi-specific antibody201910,221,224WT1 HLA class II-binding peptides and compositions and methods comprising same201910,040,865T cell receptor-like antibodies specific for a WTI peptide presented by HLA-A220189,976,137Targeted self-assembly of functionalized carbon nanotubes on tumors20189,919,037'Immunogenic WT-1 peptides and methods of use thereof'20189,629,927'Single wall nanotube constructs and uses thereof'20179,593,336'Compositions and methods for treating cancer and other diseases'20179,540,448'T cell receptor-like antibodies specific for a WTI peptide presented by HLA-A2'20179,289,519'Alpha emitting constructs and uses thereof'20169,265,816'Immunogenic WT-1 peptides and methods of use thereof'20169,233,149'WT1 HLA class II—binding peptides and compositions and methods comprising same'20169,074,000'T cell receptor-like antibodies specific for a WT1 peptide presented by HLA-A2'20159,045,756'Compositions and methods for treating cancer and other diseases'20158,840,243'Eyeglasses with frame coupled to retainer strap or band which can separate under tension'20148,765,687'WT1 HLA class II-binding peptides and compositions and methods comprising same'20148,540,965'Single wall nanotube constructs and uses therefor'20138,486,409'Alpha-emitting constructs and uses thereof'20138,021,666'Method and compositions for stimulation of an immune response to CD20 using a xenogeneic CD20 antigen'20117,845,724'Automotive seating configuration'20107,747,395'Method of inhibitor design and identification using a 3-D structure of human peptide deformylase'20107,736,651'Alpha emitting constructs and uses thereof'20107,645,454'Prostate specific antigens and uses thereof'20107,598,221'Synthetic HLA binding WT-1 peptide analogues and uses thereof'20097,488,718'Synthetic HLA binding peptide analogues and uses thereof'20097,376,614'Clearing system for an electronic-based market'20086,933,368'Increasing antibody affinity by altering glycosylation of immunoglobulin variable region'20056,887,887'Asymmetric synthesis of (S,S,R)-(-)-actinonin and its analogs and uses therefor'20056,683,162'Targeted alpha particle therapy using actinium-255 conjugates'20046,660,741'Asymmetric synthesis of (S,S,R)-(-)-actinonin and its analogs and uses therefor'20036,603,127'Bismuth-213 generator and uses thereof'20036,350,861'Antibodies with increased binding affinity'20026,156,316'Oncogene fusion protein peptide vaccines'20006,007,814'Therapeutic uses of the hypervariable region of monoclonal antibody M195 and constructs thereof'19995,730,982'Therapeutic use of hypervariable region of monoclonal antibody M195 and constructs thereof'19985,714,350'Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998–2016Patents assigned to SLOAN KETTERING INST CANCER (21)· patent assignee history
1998–2021Based in New York, NY, US· patent location history
2008–2014Based in Carlisle, MA, US· patent location history
2010Based in Northville, MI, US· patent location history
2013–2021Patents assigned to SCHEINBERG DAVID A (11)· patent assignee history
2013–2021Patents assigned to MCDEVITT MICHAEL R (6)· patent assignee history
2015–2020Patents assigned to EUREKA THERAPEUTICS INC (5)· patent assignee history
2017–2021Patents assigned to MEMORIAL SLOAN KETTERING CANCER CENTER (9)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SLOAN KETTERING INST CANCER | 21 | 1998–2016 |
| SCHEINBERG DAVID Aself | 11 | 2013–2021 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 9 | 2017–2021 |
| MCDEVITT MICHAEL R | 6 | 2013–2021 |
| EUREKA THERAPEUTICS INC | 5 | 2015–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| New York, New York, US | 37 | 1998–2021 |
| Carlisle, Massachusetts, US | 2 | 2008–2014 |
| Northville, MI, US | 1 | 2010 |